| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Laht. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry research. vol 203. issue 2-3. 2013-01-28. PMID:22981426. |
findings for cho were most consistent in the thalamus, frontal lobe and anterior cingulate cortex in schizophrenia and basal ganglia in bipolar disorder. |
2013-01-28 |
2023-08-12 |
human |
| V Oertel-Knöchel, C Knöchel, S Matura, A Rotarska-Jagiela, J Magerkurth, D Prvulovic, C Haenschel, H Hampel, D E J Linde. Cortical-basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives. Schizophrenia research. vol 138. issue 2-3. 2012-10-24. PMID:22464726. |
increased volume in the thalamus and parts of the basal ganglia and decreased volume of cortical areas and underlying white matter were thus associated with schizophrenia and its genetic vulnerability. |
2012-10-24 |
2023-08-12 |
Not clear |
| G Northof. Brain imaging in catatonia: current findings and a pathophysiologic model. CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197154. |
in the beginning of the 20th century, catatonia was considered to be the motoric manifestation of schizophrenia; therefore, neuropathologic research mostly focused on neuroanatomic substrates (ie, the basal ganglia underlying the generation of movements). |
2012-10-02 |
2023-08-12 |
Not clear |
| Sarah E Morris, Clay B Holroyd, Monica C Mann-Wrobel, James M Gol. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Frontiers in human neuroscience. vol 5. 2012-10-02. PMID:22065618. |
the results of the computational modeling suggest that schizophrenia patients exhibit weakened representation of response values, possibly due to failure of the basal ganglia to strongly associate stimuli with appropriate response alternatives. |
2012-10-02 |
2023-08-12 |
human |
| Free communications 1 pharmacology of dopamine, the Basal Ganglia and schizophrenia. Journal of psychopharmacology (Oxford, England). vol 3. issue 4. 2012-10-02. PMID:22282912. |
free communications 1 pharmacology of dopamine, the basal ganglia and schizophrenia. |
2012-10-02 |
2023-08-12 |
Not clear |
| Mireille Nieuwenhuis, Neeltje E M van Haren, Hilleke E Hulshoff Pol, Wiepke Cahn, René S Kahn, Hugo G Schnac. Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. NeuroImage. vol 61. issue 3. 2012-09-17. PMID:22507227. |
the model's discriminative pattern showed, amongst other differences, gray matter density decreases in frontal and superior temporal lobes and hippocampus in schizophrenia patients with respect to healthy controls and increases in gray matter density in basal ganglia and left occipital lobe and. |
2012-09-17 |
2023-08-12 |
human |
| Sabrina Ena, Alban de Kerchove d'Exaerde, Serge N Schiffman. Unraveling the differential functions and regulation of striatal neuron sub-populations in motor control, reward, and motivational processes. Frontiers in behavioral neuroscience. vol 5. 2011-11-10. PMID:21847377. |
severe basal ganglia dysfunction occurs in movement disorders as parkinson's and huntington's disease, and in psychiatric disorders such as schizophrenia and drug addiction. |
2011-11-10 |
2023-08-12 |
Not clear |
| Ganesan Venkatasubramanian, Naren P Rao, Rishikesh V Beher. Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia. Indian journal of psychological medicine. vol 31. issue 1. 2011-11-10. PMID:21938084. |
review of brain abnormalities in schizophrenia and obsessive-compulsive disorder (ocd) reveals involvement of similar regions namely the frontal lobe, the basal ganglia, the thalamus, and the cerebellum, in both the disorders. |
2011-11-10 |
2023-08-12 |
Not clear |
| Ahmed A Moustafa, Mark A Gluc. Computational cognitive models of prefrontal-striatal-hippocampal interactions in Parkinson's disease and schizophrenia. Neural networks : the official journal of the International Neural Network Society. vol 24. issue 6. 2011-09-30. PMID:21411277. |
disruption to different components of the prefrontal cortex, basal ganglia, and hippocampal circuits leads to various psychiatric and neurological disorders including parkinson's disease (pd) and schizophrenia. |
2011-09-30 |
2023-08-12 |
Not clear |
| Jan Kehler, Jacob Nielse. PDE10A inhibitors: novel therapeutic drugs for schizophrenia. Current pharmaceutical design. vol 17. issue 2. 2011-09-29. PMID:21355834. |
disturbances of the basal ganglia processes is heavily involved in schizophrenia. |
2011-09-29 |
2023-08-12 |
Not clear |
| Sebastian Walther, Andrea Federspiel, Helge Horn, Nadja Razavi, Roland Wiest, Thomas Dierks, Werner Strik, Thomas Jörg Mülle. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry research. vol 192. issue 2. 2011-06-28. PMID:21511443. |
resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. |
2011-06-28 |
2023-08-12 |
human |
| Sebastian Walther, Andrea Federspiel, Helge Horn, Nadja Razavi, Roland Wiest, Thomas Dierks, Werner Strik, Thomas Jörg Mülle. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry research. vol 192. issue 2. 2011-06-28. PMID:21511443. |
the findings suggest that basal ganglia motor control is impaired in schizophrenia. |
2011-06-28 |
2023-08-12 |
human |
| A Beyeler, N Kadiri, S Navailles, M Ben Boujema, F Gonon, C Le Moine, C Gross, P De Deurwaerdèr. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia. Neuroscience. vol 169. issue 1. 2011-03-04. PMID:20447448. |
serotonin2c (5-ht(2c)) receptors act in the basal ganglia, a group of sub-cortical structures involved in motor behavior, where they are thought to modulate oral activity and participate in iatrogenic motor side-effects in parkinson's disease and schizophrenia. |
2011-03-04 |
2023-08-12 |
rat |
| James A Waltz, Julie B Schweitzer, Thomas J Ross, Pradeep K Kurup, Betty J Salmeron, Emma J Rose, James M Gold, Elliot A Stei. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 12. 2011-02-16. PMID:20720534. |
abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. |
2011-02-16 |
2023-08-12 |
human |
| Sergi Ferré, Gemma Navarro, Vicent Casadó, Antoni Cortés, Josefa Mallol, Enric I Canela, Carme Lluís, Rafael Franc. G protein-coupled receptor heteromers as new targets for drug development. Progress in molecular biology and translational science. vol 91. 2010-09-28. PMID:20691958. |
dopamine and opioid receptor heteromers are the focus of intense research which is related to the possible multiple applications of their putative ligands in pathological conditions, which include basal ganglia disorders, schizophrenia and drug addiction. |
2010-09-28 |
2023-08-12 |
Not clear |
| K Fuxe, D Marcellino, D O Borroto-Escuela, M Guescini, V Fernández-Dueñas, S Tanganelli, A Rivera, F Ciruela, L F Agnat. Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS neuroscience & therapeutics. vol 16. issue 3. 2010-09-22. PMID:20345970. |
thus, other pathogenic mechanisms beside the well-known alterations in the release and/or decoding of dopamine in the basal ganglia and limbic system are involved in pd, schizophrenia and drug addiction. |
2010-09-22 |
2023-08-12 |
Not clear |
| Onno L de Klerk, Antoon T M Willemsen, Fokko J Bosker, Anna L Bartels, N Harry Hendrikse, Johan A den Boer, Rudy A Dierck. Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function. Psychiatry research. vol 183. issue 2. 2010-09-16. PMID:20620031. |
we found that patients with chronic schizophrenia under treatment with antipsychotic drugs compared with healthy controls showed a significant decrease in [(11)c]verapamil uptake in the temporal cortex, the basal ganglia, and the amygdala, and amygdalae, and a trend towards a significant decrease was seen throughout the brain. |
2010-09-16 |
2023-08-12 |
Not clear |
| Unn Kristin Haukvik, Thomas McNeil, Ragnar Nesvåg, Erik Söderman, Erik Jönsson, Ingrid Agart. No effect of obstetric complications on basal ganglia volumes in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 4. 2010-07-30. PMID:20193725. |
no effect of obstetric complications on basal ganglia volumes in schizophrenia. |
2010-07-30 |
2023-08-12 |
Not clear |
| Unn Kristin Haukvik, Thomas McNeil, Ragnar Nesvåg, Erik Söderman, Erik Jönsson, Ingrid Agart. No effect of obstetric complications on basal ganglia volumes in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 4. 2010-07-30. PMID:20193725. |
heterogeneous findings have been reported in studies of basal ganglia volumes in schizophrenia patients as compared to healthy controls. |
2010-07-30 |
2023-08-12 |
Not clear |
| Unn Kristin Haukvik, Thomas McNeil, Ragnar Nesvåg, Erik Söderman, Erik Jönsson, Ingrid Agart. No effect of obstetric complications on basal ganglia volumes in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 4. 2010-07-30. PMID:20193725. |
the basal ganglia contain dopamine receptors that are known to be involved in schizophrenia pathology and to be vulnerable to pre- and perinatal hypoxic insults. |
2010-07-30 |
2023-08-12 |
Not clear |